Please click on the speaker's name to download pdf presentations of the seminars.
Biosimilars in breast cancer – the next challenge (sponsored by an educational grant from Amgen)
J. Goncalves; [1] H. Rolighed Christensen; [2] R. Bartsch [3]
Anticoagulation - from theory to practice (sponsored by an educational grant from Bayer)
K. Malá; [4] S. Steurbaut; [5] B. van den Bemt [6]
Biosimilars in cancer care - the next challenge (financial support was provided by Pfizer Limited as a Medical and Educational Goods and Service)
R. Giuliani; [7] P. Cornes; [8] G. Befrits [9]
Synergy breakfast event - The power of automation (sponsored by an educational grant from Omnicell)
G. Honeywell; [10] G. Henneré; [11] M. J. Tamés [12]
The essentials of biologicals – past, present and future (sponsored by an educational grant from Sandoz)
Harald H. Sitte; [13] S. Simoens; [14] P. Troein [15]
Keynote 1 - A fact-based view on global health and infectious diseases
H. Nordenstedt [16]
Keynote 2 - We have a dream!
C. McKay; J. Underhill [17]
Keynote 3 - Marketing the hospital pharmacist profession
C. Picton [18]
IG1 - The efficient pharmacist prioritising tasks and designing processes
R. Fernandes; A. Jacklin [19]
IG2- The productive pharmacist - process and workforce planning
V. Zardet; M. Frachette [20]
IG3 - The effective pharmacist - the team member
A. Sinclair; [21] P. Mirbod [22]
SPD1 - Medicines shortages - a reality check?
T. Hoppe-Tichy; [23] N. Linde-Laursen [24]
SPD2 - Bridging the efficacy/effectiveness gap
A. Gouveia; [25] N. Groessmann [26]
PC1 - Clinical trial regulation and ethical committees
I. Krämer; [27] C. M. Romeo Casabona [28]
PC2 - Hospital mergers and the centralisation of production services
A. Vermes; [29] S. Crauste-Manciet [30]
PC3 - Hospital pharmacists involved in ATPM and in Risk Assessment
A. De Goede; [31] K. Saadat [32]
PC4 - Quality and risk assessment of medicines for children
D. Zanon; [33] A. Lowey [34]
PC5 - Presentation and workshop dedicated to the implementation of the Resolution [CM/Res(2016)2] on good reconstitution practices in European hospitals
H. Scheepers; [35] P. Le Brun [36]
CPS1 - Managing polypharmacy - thinking outside the box
M. Wilson; [37] C. Morrison [38]
CPS2 - Providing pharmaceutical care for patients admitted to their own bedroom
M. Rom; C. Endrell [39]
CPS3 - Antimicrobial stewardship - growing a positive culture
U. Dumpis; [40] J. Thern [41]
PQ1 - Materiovigilance (UDI – tracing - reporting)
V. Nys; [42] B. Lambaux [43]
PQ2 - Ready to administer drugs - is everything under control?
S. Sauer; [44] O. Delgado Sánchez [45]
ER1 - Clinical Trials in Paediatric Haemato-oncology: different ways for HPs to participate
M-B. Aretin; [46] F. Engels [47]
ER2 - Clinical Pharmacy Services: Absence of evidence is not evidence of absence
L.J. Kjeldsen; J. Krska [48]
ER3 - The art of writing an abstract and getting in accepted
G. Stemer; [49] T. Hoppe-Tichy [50]
Workshop 1 - The pharmacist's role in the drugs and therapeutics committee
N. Martinez-Lopez de Castro; [51] H. Plet [52]
Workshop 2 - Assessment and clinical importance of pharmacist recommendations
H. Toss; U. Gillespie [53]
Workshop 3 - Check of medication appropriateness (COMA): an instrument to implement clinical guidelines in practice
T. Van Nieuwenhuyse; C. Quintens [54]
Hospital pharmacy in Sweden, highlights and curiosities
K-J. Lindner; U. Gillespie; A. Bergkvist Christensen [55]
Student Programme: An evidence based approach to developing an individualised patient care plan
A. Tonna; K. Gibson Smith [56]
Links
[1] https://www.eahp.eu/sites/default/files/j._goncalves.pdf
[2] https://www.eahp.eu/sites/default/files/h._rolighed_christensen.pdf
[3] https://www.eahp.eu/sites/default/files/r._bartsch.pdf
[4] https://www.eahp.eu/sites/default/files/k._mala-ladova.pdf
[5] https://www.eahp.eu/sites/default/files/s._steurbaut.pdf
[6] https://www.eahp.eu/sites/default/files/b._van_den_bemt.pdf
[7] https://www.eahp.eu/sites/default/files/r._giuliani.pdf
[8] https://www.eahp.eu/sites/default/files/p._cornes.pdf
[9] https://www.eahp.eu/sites/default/files/g._befrits_0.pdf
[10] https://www.eahp.eu/sites/default/files/g._honeywell.pdf
[11] https://www.eahp.eu/sites/default/files/g._hennere.pdf
[12] https://www.eahp.eu/sites/default/files/m._j._tames.pdf
[13] https://www.eahp.eu/sites/default/files/h._h._sitte.pdf
[14] https://www.eahp.eu/sites/default/files/s._simoens.pdf
[15] https://www.eahp.eu/sites/default/files/p._troein.pdf
[16] https://www.eahp.eu/sites/default/files/h._nordenstedt.pdf
[17] https://www.eahp.eu/sites/default/files/c._mckay_and_j._underhill.pdf
[18] https://www.eahp.eu/sites/default/files/c._picton.pdf
[19] https://www.eahp.eu/sites/default/files/r._fernandes_and_a._jacklin.pdf
[20] https://www.eahp.eu/sites/default/files/m._frachette_and_v._zardet.pdf
[21] https://www.eahp.eu/sites/default/files/a._sinclair.pdf
[22] https://www.eahp.eu/sites/default/files/p._mirbod.pdf
[23] https://www.eahp.eu/sites/default/files/t._hoppe-tichy.pdf
[24] https://www.eahp.eu/sites/default/files/n._linde-laursen.pdf
[25] https://www.eahp.eu/sites/default/files/a._gouveia.pdf
[26] https://www.eahp.eu/sites/default/files/n._groessmann.pdf
[27] https://www.eahp.eu/sites/default/files/i._kraemer.pdf
[28] https://www.eahp.eu/sites/default/files/c._m._romeo_casabona.pdf
[29] https://www.eahp.eu/sites/default/files/a._vermes.pdf
[30] https://www.eahp.eu/sites/default/files/s._crauste-manciet.pdf
[31] https://www.eahp.eu/sites/default/files/a._de_goede.pdf
[32] https://www.eahp.eu/sites/default/files/k._saadat.pdf
[33] https://www.eahp.eu/sites/default/files/d._zanon.pdf
[34] https://www.eahp.eu/sites/default/files/a._lowey.pdf
[35] https://www.eahp.eu/sites/default/files/h._scheepers.pdf
[36] https://www.eahp.eu/sites/default/files/p._le_brun.pdf
[37] https://www.eahp.eu/sites/default/files/m._wilson.pdf
[38] https://www.eahp.eu/sites/default/files/c._morrison.pdf
[39] https://www.eahp.eu/sites/default/files/m._rom_and_c._endrell.pdf
[40] https://www.eahp.eu/sites/default/files/u._dumpis.pdf
[41] https://www.eahp.eu/sites/default/files/j._thern.pdf
[42] https://www.eahp.eu/sites/default/files/v._nys.pdf
[43] https://www.eahp.eu/sites/default/files/b._lambaux.pdf
[44] https://www.eahp.eu/sites/default/files/s._sauer.pdf
[45] https://www.eahp.eu/sites/default/files/o._delgado_sanchez.pdf
[46] https://www.eahp.eu/sites/default/files/m-b._aretin.pdf
[47] https://www.eahp.eu/sites/default/files/f._engels.pdf
[48] https://www.eahp.eu/sites/default/files/l.j._kjeldsen_and_j.krska.pdf
[49] https://www.eahp.eu/sites/default/files/g._stemer.pdf
[50] https://www.eahp.eu/sites/default/files/t._hoppe-tichy_0.pdf
[51] https://www.eahp.eu/sites/default/files/n._martinez-lopez_de_castro.pdf
[52] https://www.eahp.eu/sites/default/files/h._plet.pdf
[53] https://www.eahp.eu/sites/default/files/u._gillespie_and_h._toss.pdf
[54] https://www.eahp.eu/sites/default/files/t._van_nieuwenhuyse_and_c._quintens_0.pdf
[55] https://www.eahp.eu/sites/default/files/u._gillespie_k-j._kjeldsen_a._bergkvist_christensen.pdf
[56] https://www.eahp.eu/sites/default/files/a._tonna_and_k._gibson_smith_0.pdf